NEWS & EVENTS
SubjectWell news
News, press releases, and media coverage
Company also unveils integrated executive leadership team to drive scalable execution.
- CRO, Sponsors
Best-in-class merger will combine global scale, scientific rigor, and patient-first design to transform clinical trial access and execution worldwide.
- CRO, Sponsors
Suzanne Harris, SubjectWell SVP of Marketing and Communications, examines the structural, operational, and patient-level challenges limiting mental health clinical trial recruitment and outlines evidence-based approaches to improve access, engagement, and representation.
- CRO, Sponsors
- Mental Health, Women's Health
SubjectWell's real-world study found that an overwhelming majority of women surveyed experienced significant menstrual pain consistent with dysmenorrhea, but only a very small percentage had received a formal diagnosis or sought care.
- Patient Support
By integrating Patient Burden Index (PBI), Site Burden Index (SBI), and standards-of-care data into its modeling and execution, SubjectWell is redefining how sponsors design protocols, forecast feasibility, drive enrollment, and sustain long-term patient participation.
- Patient Support
SubjectWell’s new evidence-based framework integrates burden indices and standards-of-care data to help sponsors design smarter trials, predict performance, and enhance patient and site experience.
SubjectWell SVP of Marketing, Suzanne Harris, discusses our latest peer-reviewed research that uses social media as a health resource and recruitment engine.
- Patient Support
Award recognizes design excellence in advancing health, wellness and patient engagement.
Learn what an ideal patient journey could look like in a trial when site and patient support are optimized.
It’s time to transform patient recruitment
The clinical trial landscape has changed dramatically. Protocols are more complex, patient needs have evolved, and regulatory standards are ever-changing. Globalization has made finding patients even more challenging. Yet, patient recruitment strategies have remained stagnant, leading to an 80% clinical trial failure rate and $40 billion in unrecoverable losses. (BioPharma Dive. January 29, 2019.)
Their tailored approach helped us meet our recruitment target ahead of schedule. Highly recommend!
Name
Job Description
Get started with SubjectWell
Patient-centricity is paramount. Breakthroughs are in demand. Let’s change patient recruitment and commercial development together.
